We earlier observed a positive correlation between portal venous pressure (PVP) and the concentration of laminin in serum. Here we investigated whether the diagnostic efficacy could be improved by considering additional analytes and application of multivariate statistical analysis. In 102 patients with fibrotic liver disease of various etiologies we measured PVP as the gradient of the wedged and free hepatic venous pressures and determined the concentrations of hyaluronic acid and laminin in serum. Regression coefficients established by logistic regression in this group were subsequently used to predict portal hypertension (PVP >5 mmHg) in an independent group of 45 patients. By comparison with the known PVP, we obtained a sensitivity of 0.83 (confidence interval: 0.63-0.93) and a specificity of 0.82 (0.61-0.93) for diagnosis of portal hypertension by means of the concentrations of hyaluronic acid and laminin in serum. Application of the model is suggested as a tool for pre-screening and monitoring patients to be subjected to assessment of portal hypertension. The likeithood ratio, estimated by logistic regression as proposed by Albert (10), has the advantage that one can quantifr the diagnostic ability of multiple tests as a single numerical value. The predictive value of a positive test result is easily computed from the likelihood ratio and the pre-test probability of the disorder being considered (
Logistic-Regression Model for Assessing Portal Hypertension by Measuring Hyaluronic Acid (Hyaluronan) and Laminin in Serum
JUrgen Kropf,' Axel M. Gressner,1and WolfgangTlttor2
We earlier observed a positive correlation between portal venous pressure (PVP) and the concentration of laminin in serum. Here we investigated whether the diagnostic efficacy could be improved by considering additional analytes and application of multivariate statistical analysis. In 102 patients with fibrotic liver disease of various etiologies we measured PVP as the gradient of the wedged and free hepatic venous pressures and determined the concentrations of hyaluronic acid and laminin in serum. Regression coefficients established by logistic regression in this group were subsequently used to predict portal hypertension (PVP >5 mmHg) in an independent group of 45 patients. By comparison with the known PVP, we obtained a sensitivity of 0.83 (confidence interval: 0.63-0.93) and a specificity of 0.82 (0.61-0.93) for diagnosis of portal hypertension by means of the concentrations of hyaluronic acid and laminin in serum. Application of the model is suggested as a tool for pre-screening and monitoring patients to be subjected to assessment of portal hypertension. The likeithood ratio, estimated by logistic regression as proposed by Albert (10) , has the advantage that one can quantifr the diagnostic ability of multiple tests as a single numerical value. The predictive value of a positive test result is easily computed from the likelihood ratio and the pre-test probability of the disorder being considered ( 
see Methods of Computation).
A preliminary investigation (11) suggested that the prediction of portal hypertension might be improved if values for laminin and hyaluronic acid were used in combination.
This result was, however, confirmed within the same population from which it had been derived and therefore was suspected of being too optimistic (12). The aim of the present study was to validate the diagnostic efficacy of the serum concentrations of these connective-tissue components for portal hypertension in a new, i.e., independent, population of patients.
MaterIals and Methods

Subjects
We investigated two independent populations of patients with chronic liver diseases, recruited from the Stoffwechselklinik der LVA Bad Mergentheim, F.R.G.
Group A comprised 102 patients (82 men and 20 women, ages 24-71 years) with histologically verified liver fibrosis of anamnestically explored etiologies (Table 1). Serum sampled from these patients, who had been alreadyevaluated in a previous study (6), was used as the training set for the computation of the coefficients of the logistic regression.
Group B: One of us (W.T.) collected sera from 45 consecutive patients (29men and 16 women, ages 23-69 years) with liver fibrosis who were being clinically assessed for portal hypertension. The investigators performing the chemical and statistical analyses of these sera had no patient-related information.
For all patients the portal venous pressure was determined indirectly by the wedged hepatic vein pressure gradient (WHVPG) (9) . Pressure >5 mmHg was considered to be pathological. The fractions of patients with 
Specimen Collection
Venous blood was sampled in the morning from subjects who had fasted overnight. The serum was stored at -70 #{176}C for no more than two months until assay. The interval between sampling of the sera of group A and acquisition of group B was three years; the duration of both sampling periods was about two months.
Determination of Laminin and Hyaluronic Acid
Lamimn was measured in serum by a competitive radioinununoassay (Behring-Hoechst, Frankfurt, F.R.G.) with antibodies directed against antigenic determinants of fragment P1 (13, 14). Analytical details have been described before (5, 14) . Hyaluronic acid was measured by a previously described radiometric assay (Pharmacia, Uppsala, Sweden) (15) . The intra-and interassay CVs (at = 182 igfL) were 6.9% and 7.3%, respectively.
PIIINP was determined in serum by radioimmunoassay (Behring-Hoechst) as described previously (16), of which the analytical criteria are reported elsewhere (17) .
Other Analyses
Aspartate aminotransferase (AST), alanine aminotransferase (ALT), y-glutamyltransferase (GOT), and bilirubin were determined in serum by routine methods (18) .
Methods of Computation
The likelihood ratio (LR) is defined as the ratio of two probabilities:
i.e., the probability of finding value(s) X, given the presence of disease D, divided by the probability of finding x in the absence of disease V.
[Although disease (D) is considered here as a binary variable, it could take several values (8) .] Given n diagnostic tests, r = (x1, x) is a vector of n results x1, ..., x,, and the likelihood ratio can be expressed as
The unknown coefficients a0,.. . , a,, are estimated by a logistic-regression procedure.
By application of Bayes's theorem, the posterior probability (predictive value) of disease, given the test result(s) X, can be easily calculated from the likelihood ratio and the pre-test probability (prevalence) (p) of
With the procedure outlined, the number that the clinician is actually interested in, P(DIX), is obtained by a simple mathematical operation on the test results and some previously calculated coefficients.
We used the CATMOD procedure of the SAS statistic package (SAS PC V6.03; SAS Institute, Cary, NC) for computation of likelihood ratios. SAS procedure REG was used for computing multiple linear regressions between WHVP and the analytes. We tested the association between variables by using Spearman rank correlation coefficients (SAS procedure CORR). For testing differences between groups we used the Mann-Whitney U test (SAS procedure NPAR1WAY). No corrections for multiple comparisons were made.
Results
Mostly above-normal concentrations of hyaluronic acid, laminin, and PIIINP were found in both groups as compared with the mean values for the analytes in healthy subjects (Table 1) . Groups A and B were homogeneous (no significant differences) with respect to the concentrations of laminin and hyaluronic acid, and to WHVPG (Figure 1 ). There was a significant effect of etiology (alcoholic vs nonalcoholic) on the concentration of laminin (P = 0.0016 and 0.0017 for the combined groups and group A, respectively) and on WHVPG (P >0.0001 both for the combined groups and group A), but not on hyaluronic acid (P >0.05). The mean values for all analytes were highest within the group of ethanol-toxic etiologies (Table 1) . No sex-specific differences could be detected for any analyte investigated. The correlations between the analytes and WHVPG, shown in Table 2 
To facilitate the interpretation, we computed the more familiar measures of diagnostic sensitivity, specificity, and efficiency from the predictions obtained by logistic regression and the "true" WHVPG. The pro-test probabilities required for the computation of the predictive values from the likeithood ratios were taken from the frequency of diseased patients (WHVPG >5 mxnHg) within the respective groups. A predictive value of 0.5 was taken as the decision limit for positive or negative "test" results, respectively. Figure 2 shows the WHVPG within group B in relation to the computed predictive values.
The diagnostic measures for the reclassification within the training set (group A) are compiled in Table  3a . Application of the coefficients attained from the training set on group B gave the results shown in Table  3b . With hyaluronic acid alone, the sensitivity and specificity were 0.77 and 0.86, respectively, whereas with lamiin as the single variable these figures were 0.86 and 0.64, respectively. The combination of both analytes gave a sensitivity of 0.83 and a specificity of 0.82. The formula for the computation of the likelihood ratio for portal hypertension within ethanol-toxic etiologies is as follows:
The number of cases in the group of nonethanol toxic etiologies was too low to justifr the evaluation of an analogous formula for this group. In extension of the above models, etiology (coded: nonalcoholic 0, alcoholic 1) was included as an additional independent variable with laminin and hya1uronic acid. In this model signi.ficant effects (P <0.05) emerged for etiology, hyaluronic acid, and for the combinations hyaluromc acidS etiology and laminin . etiology; laminin by itself was not significant (P = 0.09). The positive significance test for laminin -etiology confirms that different relations exist between WHVP and the concentrations of laminin in serum in patients with alcoholic etiology and in those with nonalcoholic etiology.
Example
To demonstrate the steps necessary for the application of the proposed procedure, we give a detailed example, using the results for one of the patients (marked with the arrow in Figure 2) . The concentra- The likelihood ratio considerably exceeds 1, so we can strongly suspect that portal hypertension is in effect.
From an inspection of the medical files of previous investigations we determined that in 55% of all patients of this community portal hypertension had been established; i.e., the prevalence (p) of portal hypertension within our clinical setting was 0.55. We could then finally compute an individual predictive value for this patient by use of equation 3: This result shows that the individual pre-test probability for portal hypertension has increased from 0.55 to 0.99 after logistic-regression analysis.
In this example, our result was confirmed by measuring WHVPG, which was 11 mmHg for the patient considered. (If we had assumed non-ethanol-toxic etiology and had used equation 4, additionally considering the laminin concentration, essentially the same evidence would have emerged, but with lower values for the likelihood ratio, 18, and the predictive value, 0.96.)
These computations can be easily performed with the aid of a simple pocket calculator or, even more expediently, by use of a small program run on a personal computer.
Discussion
In continuation of our previous investigations (6, 11, 19), this study was designed to find a clinical chemical approach fordiagnosisof portal hypertension in pa- 0.83, specificity: 0.82) for the whole group, independent of etiology, are only slightly less. We stress, however, that these figures should be considered only as estimates of the "true" values: The small number of samples in group B gives rise to the relatively wide confidence intervals shown in Table 3 . In accordance with others (21) and in confirmation of our previous results (17,22), we found no statistical relation between PIIINP and WHVPG.
The design of the study, with independent groups of patients for establishment and verification of the discrisnination criteria, avoids common pitfalls concerning the overestimation of the diagnostic criteria when they are tested with the same data set as they are derived from (12). We cannot postulate that our results are representative for every clinical setting, because they were obtained from one (specialized) hospital, but the statistical method used can compensate for different frequencies of liver-disease patientsby adjustmentof the final predictive values. As can be seen from Figure 1 and Tables 2 and 3 (17, 27 Another explanation is based on the fact that lminin (35) and hyaluronic acid (36, 37) are very short-lived serum components, because they are actively degraded in the liver endothelial cells. A reduced clearance function in conjunction with portal hypertension might also cause or contribute to increased concentrations in serum. This is further supported by the recent observation of the dependency of the clearance kinetics or hyaluronic acid on hepatic blood flow (38). However, the striking failure of PIIINP to correlate with WHVPG, despite the fact that both mechanisms are also valid for this analyte (39, 40) , indicates that the biochemical relations are obviously much more complex.
We think that measuring hyaluronic acid and larnimm in serum is not suited as a general screening test for fibrotic liver disease in an unselected population, i.e., without prior knowledge of the prevalence of the disease. Concentrations of one or both analytes are increased in various other diseases, e.g., diabetes (41) , rheumatoid arthritis (42), tumors (13), and hyperthyroidism (43), which will result in a low diagnostic specificity. The assessment of early stages of the disease (e.g., fatty liver) is of course most desirable (21) , but one has to deal with lowered sensitivities. However, with given or strongly suspected diagnosis of chronic liver disease, especially in the case of ethanol-toxic etiologies, the determination of both of these analytes could serve at least as a tool for pre-screening those patients for whom portal venous pressure must be measured. 
